Last Wednesday the U.S. Food and Drug Administration approved Narcan, 4 milligram naloxone hydrochloride nasal spray, for over-the-counter (OTC), nonprescription use.
It is the first naloxone product approved for use without a prescription.
Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard emergency treatment for such. Narcan nasal spray was first approved by the FDA in 2015 as a prescription drug. More than 44 million doses of Narcan have been distributed since its launch in 2016.
More than 101,750 reported fatal overdoses occurred in the U.S.
Subscribe to keep reading
This story is from our archive. Get your SandPaper Annual Pass for access to our digital archive, plus everything else a pass includes. Details below.
Annual Pass — $18 Details
365-day access to:
- The complete SandPaper digital archive (stories date back to 2012).
- Full photo galleries from our photographers.
- The entire catalog of SandPaper games, puzzles and quizzes.
How it works
- Enter your email below and click to pay the one-time $18. Card details are entered on Stripe’s secure page.
- You’re in straight away — no password to create, and nothing to set up or manage.
- You stay signed in. If you’re ever signed out, or you read on a new phone or computer, we’ll email you a code to get you back in.
- Never auto-renews. Your pass is good for one year. We will email you when it expires so you can renew if you’d like.
See our site policies for more information.
Already a subscriber? We’ll email a code to get you back in.
